Cost and utilization study of antidotes: An Iranian experience

International Journal of Pharmacology

Volumn 7, Issue 1, 2011, Pages 46-49

  Nikfar, Shekoufeh ^a,b   Khatibi, Mohsen ^c   Abdollahi Asl, Akbar ^a   Abdollahi, Mohammad ^d  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b MINISTRY OF HEALTH AND MEDICAL EDUCATION   (Iran)

^c SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Antidotes; Clinical toxicology; Drug affair's; Pharmaceutical regulation; Pharmacoeconomics

Indexed keywords

4 METHYLPYRAZOLE; ACETYLCYSTEINE; ALCOHOL; AMYL NITRITE; ANTIBOTULISM POLYVALENT; ANTIDOTE; ATROPINE; BENZATROPINE MESILATE; DEFEROXAMINE; DIMERCAPROL; EDETATE CALCIUM; FERRIC FERROCYANIDE; FLUMAZENIL; GLUCAGON; IMMUNOGLOBULIN F(AB) FRAGMENT; METHYLENE BLUE; NALOXONE; OBIDOXIME; OXYGEN; PENICILLAMINE; PHYTOMENADIONE; PRALIDOXIME; PROTAMINE SULFATE; SCORPION VENOM ANTISERUM; SNAKE VENOM ANTISERUM; SODIUM NITRITE; SODIUM THIOSULFATE; SUCCIMER; UNCLASSIFIED DRUG; UNINDEXED DRUG; VENOM ANTISERUM;

COST UTILITY ANALYSIS; DEVELOPING COUNTRY; DRUG COST; DRUG UTILIZATION; ECONOMIC ASPECT; HEALTH CARE ACCESS; HEALTH CARE COST; HEALTH INSURANCE; HUMAN; IRAN; REVIEW; SYSTEMATIC REVIEW;

EID: 78649389355     PISSN: 18117775     EISSN: 18125700     Source Type: Journal    
DOI: 10.3923/ijp.2011.46.49     Document Type: Review

References (10)

1. Abdollahi, M., N. Jalali, O. Sabzevari, R. Hosseini and T. Ghanea, 1997. A retrospective study of poisoning in Tehran. J. Toxicol. Clin. Toxicol., 35: 387-393.
2. Abdollahi, M., S. Shadnia, S. Nikfar, S. Kangarlou and A. Rezaiee, 2003. Antidotes an overview. Prog. Med. Res., 1: 1-28.
3. Anonymous, 2008. Inpatients diseases status in Iran's Hospitals. Ministry of Health and Medical Education. Information Technology and Statistic Management Center, Tehran, Iran.
4. Ghazinour, M., H. Emami, J. Richter, M. Abdollahi and A. Pazhumand, 2009. Age and gender differences in the use of various poisoning methods for deliberate parasuicide cases admitted to loghman hospital in Tehran (2000-2004). Suicide Life Threat. Behav., 39: 231-239.
5. Moghadamnia, A.A. and M. Abdollahi, 2002. An epidemiological study of acute poisonings in northern Islamic Republic of Iran. Eastern Mediterr. Health J., 8: 88-94.
6. Mousavi, S., M. Mojtahedzadeh and M. Abdollahi, 2010. Place of iron chelators like desferoxamine and deferasirox in management of hyperoxia-induced lung injury; a systematic review. Int. J. Pharmacol., 6: 397-408.
7. Nikfar, S., A. Kebriaeezadeh, R. Majdzadeh and M. Abdollahi, 2005. Monitoring of National Drug Policy (NDP) and its standardized indicators conformity to decisions of the national drug selecting committee in Iran. BMC Int. Health Hum. Rights, 5: 5-5.
8. Rahimi, R., S. Nikfar and M. Abdollahi, 2006. Increased morbidity and mortality in acute human Hum. Exp. Toxicol, 25: 157-162.
9. Shadnia, S., H. Esmaily, G. Sasanian, A. Pajoumand, H. Hassanian-Moghaddam and M. Abdollahi, 2007. Pattern of acute poisoning in Tehran-Iran in 2003. Hum. Exp. Toxicol., 26: 753-756.
10. Theakston, R.D.G., D.A. Warrell and E. Griffiths, 2003. Report of a WHO workshop on the standardization and control of antivenoms. Toxicon, 41: 541-557.